News & Press Releases

The Deal quoted Member Theresa Carnegie in a recent article about how regulatory pressure on pharmacy benefit managers (PBMs) has sparked innovation and opened up investment opportunities in the industry. Increased scrutiny of larger PBMs over concerns about competition and drug prices has prompted newer PBMs to emphasize transparency.

Mintz advised Andromeda Robotics on its AU$23 million Series A capital raise, led by San Francisco’s Forerunner Ventures.

Mintz advised the underwriters in connection with the $230 million underwritten offering by Ondas Holdings Inc. of 46,000,000 shares of its common stock, which includes 6,000,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.

Member Steve Osborn was quoted in a 9fin article examining compliance concerns related to AI technologies and the steps being taken by regulators and leveraged credit market participants. The article highlights differing views among companies about whether AI could introduce decision bias, particularly in areas like underwriting.

Mintz received a pair of awards at LMG’s 2025 “Life Sciences Americas Awards” which recognize the region’s “most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice over the past twelve months.”

Bloomberg Law published an article written by Cross-Border Asset Recovery Practice Chair Kevin Ainsworth about Amaplat Mauritius Ltd. v. Zimbabwe Mining Dev. Corp., where the DC Circuit dismissed a bid to recognize a foreign court judgment confirming a foreign arbitration award against a sovereign. The court held that US federal courts lack jurisdiction under the Foreign Sovereign Immunities Act when such claims are filed after the three-year deadline, and rejected the petitioners’ implied waiver arguments.